MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: Factors that affect toxicity and cosmesis

Cancer

Volumn 101, Issue 4, 2004, Pages 727-734

  Shah, Neenad M ^a   Tenenholz, Todd ^b   Arthur, Douglas ^b   DiPetrillo, Thomas ^c   Bornstein, Bruce ^a   Cardarelli, Gene ^c   Zheng, Zhen ^c   Rivard, Mark J ^a   Kaufman, Seth ^a   Wazer, David E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Accelerated partial breast irradiation; Brachytherapy; Breast carcinoma; MammoSite; Radiation therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; IRIDIUM 192;

ADULT; AGED; ARTICLE; BALLOON CATHETER; BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; ESTHETICS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SKIN FIBROSIS;

AGED; BRACHYTHERAPY; BREAST NEOPLASMS; DATABASES, FACTUAL; DOSE FRACTIONATION; FEMALE; FIBROSIS; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIATION INJURIES; RETROSPECTIVE STUDIES; SKIN;

EID: 3543068740     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20424     Document Type: Article

References (37)

1. Rosen PP, Frachia AA, Urban JA, et al. Residual mammary carcinoma following simulated partial mastectomy. Cancer. 1975;35:739-744.
2. Holland R, Veling SHJ, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Cancer. 1985;56:979-990.
3. Faverly DRG, Hendriks JHCL, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647-659.
4. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6): relationship of local recurrence to multicentricity. Cancer. 1986;57:1717-1724.
5. Veronesi U, Liuini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328:1587-1591.
6. Liljegren G, Holmberg L, Adami HO, et al., for the Uppsala-Oreboro Breast Cancer Study Group. Sector resection with or without post-operative radiotherapy for Stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst. 1994;86:717-722.
7. Clark RM, Whelan T, Levine M, et al., for the Ontario Clinical Oncology Group. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. An update. J Natl Cancer Inst. 1996;88:1659-1664.
8. Fisher ER, Anderson S, Redmond C, et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathologic findings from NSABP protocol B-06. Semin Surg Oncol. 1992;8:161-166.
9. Gage I, Recht A, Gelman R, et al. Long-term outcome following breast conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245-251.
10. Wazer DE, Schmidt-Ullrich RK, Schmid C, et al. Factors determining outcome for breast-conserving irradiation with margin directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys. 1998;40:851-858.
11. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326:1097-1101.
12. Dolan JT, Granchi TS, Miller CC III, et al. Low use of breast conservation surgery in medically indigent populations. Am J Surg. 1999;178:470-474.
13. Hevert-Croteau N, Brisson J, Latreille J, et al. Compliance with consensus recommendation for the treatment of early stage breast carcinoma in elderly women. Cancer. 1999;85:1104-1113.
14. Du X, Freeman JL, Freeman DH, et al. Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1985. J Gerontol A Biol Sci Med Sci. 1999;54:474-478.
15. Athas WF, Adams-Cameron M, Hunt WC, et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92:269-271.
16. Arthur D, Vicini F, Kuske RR, et al. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2002;1:184-190.
17. Wazer DE, Berle L, Graham R, et al. Preliminary results of a Phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53:889-897.
18. Vicini FA, Chen PY, Fraile M, et al. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial. Int J Radiat Oncol Biol Phys. 1997;38:301-310.
19. Kuske R, Bolton JS, McKinnon WMP, et al. Five-year results of a prospective Phase II trial of wide-volume brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0-1 breast cancer [abstract]. Int J Radiat Oncol Biol Phys. 1998:42(Suppl 1):181.
20. Kuske R, Bolton JS. A Phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma. Radiation Therapy Oncology Group Pub. No. 1055. Philadelphia: Radiation Therapy Oncology Group, 1995.
21. Clarke DH, Vicini FA, Jacobs H, et al. High dose rate brachytherapy for breast cancer. In: Nag S, editor. High dose rate brachytherapy: a textbook. Arnonk, NY: Futura Publishing, 1994:321-329.
22. Fentimen IS, Poole C, Tong D, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer. 1991;27:447-450.
23. Perera F, Engel J, Holliday R, et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol. 1997;65:263-267.
24. Martinez AA, Chen PY, Gustafson G, et al. Irradiation of the tumor bed alone after lumpectomy with high dose rate brachytherapy. In: Proceedings of the 19th Annual Meeting of the American Brachytherapy Society, 1997.
25. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg. 2000;180:299-304.
26. Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993-2001.
27. Vicini FA, Jaffray DA, Horwitz EM, et al. Implementation of 3D-virtual brachytherapy in the management of breast cancer: a description of a new method of interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40:629-635.
28. Vicini FA, Kini VR, Chen P, et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol. 1999;70:33-40.
29. Vicini FA, Kestin LL, Edmundson GK, et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys. 1999;45:803-810.
30. Baglan KL, Martinez AA, Frazier RC, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2001;50:1003-1011.
31. Wazer DE, Lowther D, Boyle T, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer Int J Radiat Oncol Biol Phys. 2001;50:107-111.
32. Zwicker RD, Schmidt-Ullrich RK. Dose uniformity in a planar interstitial implant system. Int J Radiat Oncol Biol Phys. 1995;31:149-155.
33. Wazer DE, DiPetrillo TA, Schmidt-Ullrich RK, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early stage breast carcinoma. J Clin Oncol. 1992;10:356-363.
34. Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2002;52:1132-1139.
35. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289-293.
36. Wazer DE, Kramer B, Schmid C, et al. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys. 1997;39:381-393.
37. Kramer B, Arthur DW, Ulin K, et al. Cosmetic outcome in patients receiving an interstitial implant as part of breast conservation therapy. Radiology. 1999;213:61-66.